Neutralization of heparin by protamine. Time for a change?
Schapira
M
M
Christman
B W
BW
D000818:Animals; D005112:Extracorporeal Circulation; D006494:Heparin Antagonists / Q000009:adverse effects*; D006495:Heparin, Low-Molecular-Weight / Q000037:antagonists & inhibitors; D006583:Hexadimethrine Bromide / Q000627:therapeutic use; D006801:Humans; D006976:Hypertension, Pulmonary / Q000139:chemically induced*; D011479:Protamines / Q000009:adverse effects*; D012756:Sheep; D013928:Thromboxane A2 / Q000031:analogs & derivatives / Q000037:antagonists & inhibitors / Q000627:therapeutic use
D006494:Heparin Antagonists; D006495:Heparin, Low-Molecular-Weight; D011479:Protamines; C054215:SQ 30741; D006583:Hexadimethrine Bromide; D013928:Thromboxane A2